U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT06940700) titled 'Clinical Study on the Efficacy and Safety of SHR-4597 Inhalant in Adult Patients With Asthma' on April 16.
Brief Summary: To evaluate the efficacy and safety of SHR-4597 inhalants in adults with asthma: a multicenter, randomized, open-label, positive-controlled Phase II clinical study
Study Start Date: April, 2025
Study Type: INTERVENTIONAL
Condition:
Asthma
Intervention:
DRUG: SHR4597
SHR4597
DRUG: Budesonide inhalant
Budesonide inhalant
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd
Disclaimer: Curated by HT Syndication....